LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00033333
 40.14 84.90 256 3682 0.0695 0.2250
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 40.14 84.90 3303 3682 0.8971 0.9604
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 41.84 84.90 320 4003 0.0799 0.2696
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 41.84 84.90 2901 4003 0.7247 0.8874
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 41.84 84.90 254 4003 0.0635 0.2179
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 41.84 84.90 3528 4003 0.8813 0.9551
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 43.55 84.90 373 4287 0.0870 0.2990
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 43.55 84.90 3063 4287 0.7143 0.8846
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 43.55 84.90 271 4287 0.0632 0.2277
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 43.55 84.90 3719 4287 0.8673 0.9503
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 45.25 84.90 414 4539 0.0912 0.3178
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 45.25 84.90 3242 4539 0.7141 0.8861
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 45.25 84.90 317 4539 0.0698 0.2580
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 45.25 84.90 4064 4539 0.8952 0.9618
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 46.95 84.90 486 4952 0.0981 0.3464
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 46.95 84.90 3461 4952 0.6988 0.8815
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 46.95 84.90 362 4952 0.0731 0.2805
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 46.95 84.90 4312 4952 0.8707 0.9533
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 48.65 84.90 521 5328 0.0978 0.3550
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 48.65 84.90 3641 5328 0.6833 0.8764
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 48.65 84.90 291 5328 0.0546 0.2291
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 48.65 84.90 4557 5328 0.8552 0.9483
MN20160318_Q02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 50.36 84.90 597 5651 0.1056 0.3799
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 50.36 84.90 3943 5651 0.6977 0.8846
MN20160318_Q02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 50.36 84.90 409 5651 0.0724 0.2964
MN20160318_Q02
E21